Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COTRID: DuoStim Trigger Comparison
NCT05321511Phase 4Unknown
- Sponsor
- Instituto Bernabeu
- Start
- Mar 2022
- Primary completion
- Dec 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of triptorelin and recombinant human chorionic gonadotrophin in poor ovarian response (POR) (3 arms), sponsored by Instituto Bernabeu. Primary endpoints: Number of retrieved oocytes and Number of mature (MII) oocytes. Status: unknown.
02
Drugs
triptorelinrecombinant human chorionic gonadotrophin
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on NCT05321511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05321511.